4,4'-Methylenedianiline (MDA) -- 29 CFR 1926.60

Forms and Documents

Document Name	Status

No forms / supporting documents in this ICR. Check IC Document Collections.

IC Document Collections

IC ID	Document Title	Status
14125	4,4'-Methylenedianiline (MDA) -- 29 CFR 1926.60	Migrated

ICR Details

OMB Control No: 1218-0183	ICR Reference No: 199808-1218-004
Status: Historical Active	Previous ICR Reference No: 199506-1218-006
Agency/Subagency: DOL/OSHA	Agency Tracking No:
Title: 4,4'-Methylenedianiline (MDA) -- 29 CFR 1926.60
Type of Information Collection: Extension without change of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 10/09/1998
	Date Received in OIRA: 08/11/1998
Terms of Clearance: Approved consistent with DOL clarification memos of 10-2-98 and 10-9-98. Previous terms of clearance have not been satisfied so approval is granted for 18 months by which time consolidation and elimination of duplicative provisions as described in the "New OSHA" will be undertaken.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	04/30/2000	04/30/2000	10/31/1998
Responses	2,848	0	3,529
Time Burden (Hours)	1,796	0	2,178
Cost Burden (Dollars)	59,000	0	0

---

Abstract: The standard requires employers to monitor employee exposure to MDA, to provide medical surveillance, to train employees about the hazards of MDA, and to establish and maintain accurate records of employee exposure to MDA. These records will be used by employers, employees, physicians, and the Government to ensure that employees are not being harmed by exposure to MDA. MDA.

---

Authorizing Statute(s): None

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:

---

Federal Register Notices & Comments

Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
4,4'-Methylenedianiline (MDA) -- 29 CFR 1926.60

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	2,848	3,529	0	0	-681	0
Annual Time Burden (Hours)	1,796	2,178	0	0	-382	0
Annual Cost Burden (Dollars)	59,000	0	0	0	59,000	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $0

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? Uncollected

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? Uncollected

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? Uncollected

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 08/11/1998

---